CREB1 and melanoma: This conclusion is supported by our results that GCP‐2 treatment of A375 melanoma cells, which harbor a mutation in the phosphorylation (activation) site of CREB, is neither able to generate a migratory response (Figure 4H) nor to grow in an anchorage‐independent manner (Figure 4l).